PRIME GRANT

U19AG065188

Cooperative Agreement

Overview

Awardee
Duke University
Grant Description
Pragmatic evaluation of events and benefits of lipid-lowering in older adults (PREVENTABLE)
Grant Program (CFDA)
93.837 - Cardiovascular Diseases Research
Awarding Agency
National Institute on Aging (NIA) [HHS - NIH]
Funding Agency
National Heart Lung and Blood Institute (NHLBI) [HHS - NIH]
Place of Performance
North Carolina United States
Geographic Scope
State-Wide
Related Opportunity
Clinical Trial on Effects of Statins in Older Adults without Clinical Cardiovascular Disease (U19 Clinical Trial Required) (RFA-AG-19-020)
Notes
Amendment Since initial award the End Date has been extended from 08/31/26 to 08/31/27 and the total obligations have increased 540% from $9,403,579 to $60,183,162.
Duke University was awarded Cooperative Agreement U19AG065188 worth $60,183,162 from National Heart Lung and Blood Institute in September 2019. The grant has a duration of 8 years and was awarded through assistance program 93.837 Cardiovascular Diseases Research.

Status
(Ongoing)

Last Modified 9/5/23

Period of Performance
9/30/19
Start Date
8/31/27
End Date
50.0% Complete

Funding Split
$60.2M
Federal Obligation
$0.0
Non-Federal Obligation
$60.2M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Subgrant Awards

Disclosed subgrants for U19AG065188

Transaction History

Modifications to U19AG065188

Additional Detail

Award ID FAIN
U19AG065188
SAI Number
U19AG065188-3909195544
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NN00 NIH NATIONAL INSITUTE ON AGING
Funding Office
75NH00 NIH NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
Performance District
NC-NC-04
Senators
Thom Tillis
Ted Budd
Modified: 9/5/23